PubMed

Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM.

Tatti P, Pahor M, Byington RP, Di Mauro P, Guarisco R, Strollo G, Strollo F.

Diabetes Care. 1998 Apr;21(4):597-603.PMID: 9571349 [PubMed - indexed for MEDLINE]Related articlesFree article

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.

JAMA. 2002 Dec 18;288(23):2981-97. Erratum in: JAMA 2003 Jan 8;289(2):178. JAMA. 2004 May 12;291(18):2196. PMID: 12479763 [PubMed - indexed for MEDLINE]Related articlesFree article

New evidence on the prevention of cardiovascular events in hypertensive patients with type 2 diabetes.

Pahor M, Psaty BM, Furberg CD.

J Cardiovasc Pharmacol. 1998;32 Suppl 2:S18-23. Review.PMID: 9736437 [PubMed - indexed for MEDLINE]Related articles

Effects of amlodipine fosinopril combination on microalbuminuria in hypertensive type 2 diabetic patients.

Fogari R, Preti P, Zoppi A, Rinaldi A, Corradi L, Pasotti C, Poletti L, Marasi G, Derosa G, Mugellini A, Voglini C, Lazzari P.

Am J Hypertens. 2002 Dec;15(12):1042-9.PMID: 12460699 [PubMed - indexed for MEDLINE]Related articles

Therapeutic benefits of ACE inhibitors and other antihypertensive drugs in patients with type 2 diabetes.

Pahor M, Psaty BM, Alderman MH, Applegate WB, Williamson JD, Furberg CD.

Diabetes Care. 2000 Jul;23(7):888-92.PMID: 10895836 [PubMed - indexed for MEDLINE]Related articlesFree article

Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathy.

Berl T, Hunsicker LG, Lewis JB, Pfeffer MA, Porush JG, Rouleau JL, Drury PL, Esmatjes E, Hricik D, Parikh CR, Raz I, Vanhille P, Wiegmann TB, Wolfe BM, Locatelli F, Goldhaber SZ, Lewis EJ; Irbesartan Diabetic Nephropathy Trial. Collaborative Study Group.

Ann Intern Med. 2003 Apr 1;138(7):542-9.PMID: 12667024 [PubMed - indexed for MEDLINE]Related articlesFree article

Clinical events in high-risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensin-converting enzyme inhibitor in the antihypertensive and lipid-lowering treatment to prevent heart attack trial.

Leenen FH, Nwachuku CE, Black HR, Cushman WC, Davis BR, Simpson LM, Alderman MH, Atlas SA, Basile JN, Cuyjet AB, Dart R, Felicetta JV, Grimm RH, Haywood LJ, Jafri SZ, Proschan MA, Thadani U, Whelton PK, Wright JT; Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group.

Hypertension. 2006 Sep;48(3):374-84. Epub 2006 Jul 24.PMID: 16864749 [PubMed - indexed for MEDLINE]Related articlesFree article

Comorbidity of hypertension and diabetes: the fosinopril versus amlodipine cardiovascular events trial (FACET)

Sowers JR.

Am J Cardiol. 1998 Nov 12;82(9B):15R-19R.PMID: 9822138 [PubMed - indexed for MEDLINE]Related articles

Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril.

Wright JT Jr, Dunn JK, Cutler JA, Davis BR, Cushman WC, Ford CE, Haywood LJ, Leenen FH, Margolis KL, Papademetriou V, Probstfield JL, Whelton PK, Habib GB; ALLHAT Collaborative Research Group.

JAMA. 2005 Apr 6;293(13):1595-608.PMID: 15811979 [PubMed - indexed for MEDLINE]Related articlesFree article

Antihypertensive pharmacogenetic effect of fibrinogen-beta variant -455G>A on cardiovascular disease, end-stage renal disease, and mortality: the GenHAT study.

Lynch AI, Boerwinkle E, Davis BR, Ford CE, Eckfeldt JH, Leiendecker-Foster C, Arnett DK.

Pharmacogenet Genomics. 2009 Jun;19(6):415-21.PMID: 19352213 [PubMed - indexed for MEDLINE]Related articles

A clinical trial in type 2 diabetic nephropathy.

Lewis EJ, Hunsicker LG, Rodby RA; Collaborative Study Group.

Am J Kidney Dis. 2001 Oct;38(4 Suppl 1):S191-4.PMID: 11576953 [PubMed - indexed for MEDLINE]Related articles

Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial.

Nissen SE, Tuzcu EM, Libby P, Thompson PD, Ghali M, Garza D, Berman L, Shi H, Buebendorf E, Topol EJ; CAMELOT Investigators.

JAMA. 2004 Nov 10;292(18):2217-25.PMID: 15536108 [PubMed - indexed for MEDLINE]Related articlesFree article

Hypertension and diabetes and the Fosinopril versus Amlodipine Cardiovascular Events Trial (FACET). More ammunition against surrogate end points.

Califf RM, Granger CB.

Diabetes Care. 1998 Apr;21(4):655-7. No abstract available. PMID: 9571359 [PubMed - indexed for MEDLINE]Related articlesFree article

The Fosinopril versus Amlodipine Cardiovascular Events Trial (FACET) and combination therapies.

Pahor M, Tatti P.

Am J Cardiol. 1999 Mar 1;83(5):819-20. No abstract available. PMID: 10080455 [PubMed - indexed for MEDLINE]Related articles

Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial.

Wright JT Jr, Bakris G, Greene T, Agodoa LY, Appel LJ, Charleston J, Cheek D, Douglas-Baltimore JG, Gassman J, Glassock R, Hebert L, Jamerson K, Lewis J, Phillips RA, Toto RD, Middleton JP, Rostand SG; African American Study of Kidney Disease and Hypertension Study Group.

JAMA. 2002 Nov 20;288(19):2421-31. Erratum in: JAMA. 2006 Jun 21;295(23):2726. PMID: 12435255 [PubMed - indexed for MEDLINE]Related articlesFree article

Amlodipine versus angiotensin II receptor blocker; control of blood pressure evaluation trial in diabetics (ADVANCED-J).

Kawamori R, Daida H, Tanaka Y, Miyauchi K, Kitagawa A, Hayashi D, Kishimoto J, Ikeda S, Imai Y, Yamazaki T.

BMC Cardiovasc Disord. 2006 Oct 9;6:39.PMID: 17029631 [PubMed - indexed for MEDLINE]Related articlesFree article

A random comparison of fosinopril and nifedipine GITS in patients with primary renal disease.

Marin R, Ruilope LM, Aljama P, Aranda P, Segura J, Diez J; Investigators of the ESPIRAL Study. Efecto del tratamiento antihipertensivo Sobre la Progresión de la Insuficiencia RenAL en pacientes no diabéticos.

J Hypertens. 2001 Oct;19(10):1871-6.PMID: 11593109 [PubMed - indexed for MEDLINE]Related articles

Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Barzilay JI, Davis BR, Cutler JA, Pressel SL, Whelton PK, Basile J, Margolis KL, Ong ST, Sadler LS, Summerson J; ALLHAT Collaborative Research Group.

Arch Intern Med. 2006 Nov 13;166(20):2191-201.PMID: 17101936 [PubMed - indexed for MEDLINE]Related articlesFree article

Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study.

Otero ML, Claros NM; Study Investigators Group.

Clin Ther. 2005 Feb;27(2):166-73.PMID: 15811479 [PubMed - indexed for MEDLINE]Related articles

Effects of cilazapril and amlodipine on kidney function in hypertensive NIDDM patients.

Velussi M, Brocco E, Frigato F, Zolli M, Muollo B, Maioli M, Carraro A, Tonolo G, Fresu P, Cernigoi AM, Fioretto P, Nosadini R.

Diabetes. 1996 Feb;45(2):216-22.PMID: 8549868 [PubMed - indexed for MEDLINE]Related articles